Human Food Safety Implications of Variation in Food Animal Drug Metabolism

Violative drug residues in animal-derived foods are a global food safety concern. The use of a fixed main metabolite to parent drug (M/D) ratio determined in healthy animals to establish drug tolerances and withdrawal times in diseased animals results in frequent residue violations in food-producing animals. We created a general physiologically based pharmacokinetic model for representative drugs (ceftiofur, enrofloxacin, flunixin, and sulfamethazine) in cattle and swine based on extensive published literature. Simulation results showed that the M/D ratio was not a fixed value, but a time-dependent range. Disease changed M/D ratios substantially and extended withdrawal times; these effects exhibited drug- and species-specificity. These results challenge the interpretation of violative residues based on the use of the M/D ratio to establish tolerances for metabolized drugs.

[1]  R. Gehring,et al.  Excretory, Secretory, and Tissue Residues after Label and Extra-label Administration of Flunixin Meglumine to Saline- or Lipopolysaccharide-Exposed Dairy Cows. , 2015, Journal of agricultural and food chemistry.

[2]  G. Paulson,et al.  Depletion kinetics of 14C-sulfamethazine [4-amino-N-(4, 6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine. , 1986, Drug Metabolism And Disposition.

[3]  S. Sundlof,et al.  Food Animal Residue Avoidance Databank (FARAD): An Automated Pharmacologic Databank for Drug and Chemical Residue Avoidance. , 1986, Journal of food protection.

[4]  S. A. Brown,et al.  Ceftiofur hydrochloride: plasma and tissue distribution in swine following intramuscular administration at various doses. , 1996, Journal of veterinary pharmacology and therapeutics.

[5]  R. Gehring,et al.  A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling. , 2015, Journal of pharmaceutical sciences.

[6]  Comparison of plasma pharmacokinetics and bioavailability of ceftiofur sodium and ceftiofur hydrochloride in pigs after a single intramuscular injection. , 1999, Journal of veterinary pharmacology and therapeutics.

[7]  C. Maltecca,et al.  Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine , 2015, PloS one.

[8]  R. Gehring,et al.  Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modelling , 2015, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[9]  J. Riviere,et al.  Tabulation of FARAD Comparative and Veterinary Pharmacokinetic Data , 2006 .

[10]  G. Ziv,et al.  Tissue Distribution and Residues of Antibiotics in Normal and Emergency - Slaughtered Dairy Cows After Intramammary Treatment. , 1978, Journal of Food Protection.

[11]  P. Toutain,et al.  Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse. , 2010, Equine veterinary journal.

[12]  J. Riviere,et al.  Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. , 2005, American journal of veterinary research.

[13]  T. Vree,et al.  Age and dosage dependency in the plasma disposition and the renal clearance of sulfamethazine and its N4-acetyl and hydroxy metabolites in calves and cows. , 1986, American journal of veterinary research.

[14]  M. Jacob,et al.  Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteria. , 2016, Journal of veterinary pharmacology and therapeutics.

[15]  J. Riviere,et al.  Screening and Confirmatory Analyses of Flunixin in Tissues and Bodily Fluids after Intravenous or Intramuscular Administration to Cull Dairy Cows with or without Lipopolysaccharide Challenge. , 2016, Journal of agricultural and food chemistry.

[16]  D. E. Nelson,et al.  Pharmacokinetics of sulfamethazine in male, female and castrated male swine. , 1984, Journal of veterinary pharmacology and therapeutics.

[17]  M. Sheffer,et al.  CHARACTERIZATION AND APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS IN RISK ASSESSMENT , 2011 .

[18]  K. Odensvik,et al.  High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug. , 1995, American journal of veterinary research.

[19]  P. Nielsen,et al.  Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. , 1997, Pharmacology & toxicology.

[20]  Jim E Riviere,et al.  Health concerns and management of select veterinary drug residues. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  B. K. Park,et al.  Altered pharmacokinetics of enrofloxacin in experimental models of hepatic and renal impairment , 2009, Veterinary Research Communications.

[22]  P. Chiap,et al.  Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. , 2010, Journal of veterinary pharmacology and therapeutics.

[23]  Z. Zeng,et al.  Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine , 2012, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[24]  C. Maltecca,et al.  The effect of breed and sex on sulfamethazine, enrofloxacin, fenbendazole and flunixin meglumine pharmacokinetic parameters in swine. , 2014, Journal of veterinary pharmacology and therapeutics.

[25]  X. Miao,et al.  Pharmacokinetics of ampicillin and sulfadimidine in pigs infected experimentally with Streptococcus suum. , 1997, Journal of veterinary pharmacology and therapeutics.

[26]  A. Dreisbach,et al.  The effect of chronic renal failure on drug metabolism and transport , 2008, Expert opinion on drug metabolism & toxicology.

[27]  S. A. Brown,et al.  Comparison of plasma pharmacokinetics and bioequivalence of ceftiofur sodium in cattle after a single intramuscular or subcutaneous injection. , 2000, Journal of veterinary pharmacology and therapeutics.

[28]  R. Gehring,et al.  Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans. , 2015, Journal of pharmaceutical sciences.

[29]  J. Peggins,et al.  Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin. , 2010, Research in veterinary science.

[30]  R. Zaylskie,et al.  Steady state kinetics of 14C-sulfamethazine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine. , 1986, Drug Metabolism And Disposition.

[31]  D. Foster,et al.  Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. , 2007, Journal of veterinary pharmacology and therapeutics.

[32]  F. Aarestrup,et al.  Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. , 2002, Journal of veterinary pharmacology and therapeutics.

[33]  R. Gehring,et al.  Impact of an experimental PRRSV and Streptococcus suis coinfection on the pharmacokinetics of ceftiofur hydrochloride after intramuscular injection in pigs. , 2015, Journal of veterinary pharmacology and therapeutics.

[34]  J. Riviere,et al.  Comparison of ELISA and LC-MS/MS for the measurement of flunixin plasma concentrations in beef cattle after intravenous and subcutaneous administration. , 2013, Journal of agricultural and food chemistry.

[35]  G. Smith,et al.  A physiologically based pharmacokinetic model linking plasma protein binding interactions with drug disposition. , 2009, Research in veterinary science.

[36]  M. Rantala,et al.  Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. , 2002, Journal of veterinary pharmacology and therapeutics.

[37]  J. D. Weber,et al.  Comparative Depletion of Sulfamethazine in Bob Veal, Fancy Veal, and Replacement Calves. , 1990, Journal of food protection.

[38]  A. Tantituvanont,et al.  Pharmacokinetics of ceftiofur hydrochloride in pigs infected with porcine reproductive and respiratory syndrome virus. , 2008, The Journal of antimicrobial chemotherapy.

[39]  J. Riviere,et al.  Comparison of pharmacokinetics and milk elimination of flunixin in healthy cows and cows with mastitis. , 2015, Journal of the American Veterinary Medical Association.

[40]  V. Rodighiero Effects of Liver Disease on Pharmacokinetics , 1999, Clinical pharmacokinetics.

[41]  S. A. Brown,et al.  Effects of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle. , 1996, Journal of veterinary pharmacology and therapeutics.

[42]  J. Riviere,et al.  Use of Probabilistic Modeling within a Physiologically Based Pharmacokinetic Model To Predict Sulfamethazine Residue Withdrawal Times in Edible Tissues in Swine , 2006, Antimicrobial Agents and Chemotherapy.

[43]  R. Upton Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. , 2008, Journal of pharmacological and toxicological methods.

[44]  R. Gehring,et al.  Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment. , 2016, Journal of veterinary pharmacology and therapeutics.

[45]  A. Blikslager,et al.  Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs. , 2012, Journal of veterinary pharmacology and therapeutics.

[46]  J. Riviere,et al.  Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus) , 2014, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[47]  A. Craigmill A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. , 2003, Journal of veterinary pharmacology and therapeutics.

[48]  Anna K. Johnson,et al.  Pharmacokinetics of flunixin meglumine in mature swine after intravenous, intramuscular and oral administration , 2013, BMC Veterinary Research.

[49]  Y. Hwang,et al.  Effects of acute hepatic and renal failure on pharmacokinetics of flunixin meglumine in rats. , 2011, Experimental animals.